Extended Access Program With Lorcaserin For The Treatment of Dravet Syndrome and Other Refractory Epilepsies

Exploring the Safety And Tolerability of Doses of E2007 up to a Maximum of 12 mg In Patients With Refractory Partial Seizures

NCT00416195 ·Status: COMPLETED ·Phase: PHASE2

Bioavailability, Safety and Tolerability of Diazepam Nasal Spray Versus Diazepam Rectal Gel (Diastat®)

NCT02474407 ·Status: TERMINATED ·Phase: PHASE2

An Open-Label, Safety and Tolerability Study of Chronic Intermittent Use of Diazepam Nasal Spray.

NCT02316847 ·Status: TERMINATED ·Phase: PHASE2

Study Of The Safety And Efficacy Of Lyrica In The Treatment Of Newly Diagnosed Partial Epilepsy

NCT00280059 ·Status: COMPLETED ·Phase: PHASE3

Fenfluramine for Adult Dravet Patients

NCT05560282 ·Status: TERMINATED ·Phase: PHASE3

Cardiac Arrhythmias in Dravet Syndrome

NCT02415686 ·Status: COMPLETED

Open-Label Extension Study to Assess the Safety and Seizure Frequency Associated With Lacosamide for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy

NCT01118962 ·Status: COMPLETED ·Phase: PHASE2

Anti-Epilepsy Medication Valproate Administered Via ICV Route and Catheters and Pumps for CSF Infusion

NCT04529954 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures

NCT00520741 ·Status: COMPLETED ·Phase: PHASE3

Study to Assess Intracerebroventricular (ICV) Delivery of CT-010 in Subjects With Focal Seizures, With Temporal Lobe Onset With or Without Secondary Generalization

NCT04153175 ·Status: TERMINATED ·Phase: PHASE2

Retigabine Efficacy and Safety Trial for Partial Onset Refractory Seizures in Epilepsy

NCT00235755 ·Status: COMPLETED ·Phase: PHASE3

Dose Response Study of Zonegran in Patients With Newly Diagnosed Epilepsy

NCT00056576 ·Status: COMPLETED ·Phase: PHASE3

Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

NCT00351611 ·Status: COMPLETED ·Phase: PHASE4

Ataluren for Nonsense Mutation in CDKL5 and Dravet Syndrome

NCT02758626 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

NCT00866775 ·Status: COMPLETED ·Phase: PHASE3

A Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal Epilepsy

NCT02495844 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of Lacosamide as Additional Therapy in Patients Suffering From Epileptic Tonic-Clonic Seizures

NCT02408549 ·Status: COMPLETED ·Phase: PHASE3

Evaluate the Efficacy of BGG492 as Adjunctive Treatment in Patients With Refractory Partial Onset Seizures

NCT01167335 ·Status: WITHDRAWN ·Phase: PHASE2

Compassionate Use Program With Lacosamide in Patients With Partial-onset or Generalized Tonic-clonic Seizures

NCT03559673 ·Status: NO_LONGER_AVAILABLE

Eslicarbazepine Acetate Monotherapy Long Term Study

NCT00910247 ·Status: COMPLETED ·Phase: PHASE3

Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures

NCT00113165 ·Status: COMPLETED ·Phase: PHASE3

Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy

NCT03283371 ·Status: COMPLETED ·Phase: PHASE2

A Prospective, Observational Study On The Effectiveness Of New Antiepileptic Drugs As First Bitherapy In The Daily Clinical Practice

NCT00855738 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

NCT01422720 ·Status: COMPLETED ·Phase: PHASE3

LAMICTAL (Lamotrigine) For The Treatment Of Absence Seizures

NCT00144872 ·Status: COMPLETED ·Phase: PHASE1